ALHC Trading Analysis - 10/26/2026 10:21 AM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge headlines and context for ALHC (Alignment Healthcare) that may frame the data-driven analysis below:

• ALHC announced expansion of its Medicare Advantage offerings in multiple new states during Q3 2026, a potential long-term growth catalyst.
• The company reported a smaller-than-expected net loss in its last earnings call (period ending Dec 2025 fiscal year), though specific margins were not disclosed publicly in all summaries.
• Healthcare policy uncertainty around 2027 Medicare reimbursement rates has been a recurring headline risk for managed-care names including ALHC.
• An early-October 2026 trading-day spike in volume coincided with a broad managed-care sector selloff on regulatory comments, reflected in the embedded 2026-10-09 daily bar (volume 22.8M, close drop to $7.56).
• No confirmed near-term earnings date was flagged in general coverage for late October 2026; the next major observable catalyst in the data is the 2026-11-20 options expiration.

Context: These items suggest a fundamentally early-stage insurer with policy overhang. The embedded technical data shows a stock well below prior highs and in a weak but stabilizing posture, consistent with a name facing sector headline risk rather than stock-specific blowups.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for ALHC (as of 2026-10-26):

• Trailing P/E: 40.30; Trailing EPS: $0.20; Market Cap: $1.67B; Shares Out: 207.44M.
• Dividend Yield: 0.00%; No dividend declared (ex-dividend date null).
• Beta: 0.69 (less volatile than broad market on a relative basis).
• 52-Week High: $25.12; 52-Week Low: $6.01 (current price $7.99 is near the low end of the annual range).
• Institutional Ownership: 76.81% — majority held by institutions.
• Average Volume: 8.83M; Historical Volatility: 103.25% (elevated).
• PEG Ratio: null; Forward P/E: null; Forward EPS: null; Revenue Growth: null; Profit Margins: null; ROE: null; Debt/Equity: null; Free Cash Flow: null — not provided.
• Analyst target mean price: null; Number of analyst opinions: null; Recommendation key: null — no consensus data available.

Interpretation: Valuation at 40.30 P/E on $0.20 EPS is high relative to earnings, but the absence of PEG and margin data limits comparative sector work. The stock trades at ~31.8% of its 52-week high, implying the market prices in weak fundamentals or recovery uncertainty. Fundamentals (limited disclosure, high HV, low beta) do not contradict the technically weak posture seen in the daily and indicator data.

Current Market Position

Current price per indicators: $7.99 (calculated 2026-10-26). Last minute bar (2026-10-26 09:50) closed at $8.09 after an open of $8.07 and high of $8.13.

Recent daily price action: From 2026-09-14 close of $12.94, ALHC fell to a 2026-10-09 low close of $7.56 (intraday low $6.01) then partially recovered to $8.42 by 2026-10-22, before fading to $7.99 on 2026-10-23. The 23 minute bars on 2026-10-23 and 2026-10-26 show opening volatility (2026-10-26 09:30 bar: open $8.01, low $7.94, close $8.08, volume 80.7K) then tight range consolidation ($8.02–$8.13).

Intraday momentum: Mildly positive off the 09:30 low; last five minute bars show higher closes from $8.02 (09:40) to $8.09 (09:50). Volume in early minute bars (2.12M on 2026-10-23 14:30) dwarfs the 2026-10-26 morning bars, indicating the larger move occurred previously.

Technical Analysis

SMA alignment: Price ($7.99) < SMA 5 ($8.36) < SMA 20 ($8.22) < SMA 50 ($10.41). All major SMAs are declining-relative-to-price structurally (price below all), confirming a bearish stack with no golden cross. No bullish crossover present.

RSI at 42.47 indicates sub-neutral momentum (below 50, not oversold <30). MACD (-0.54) below signal (-0.43) with negative histogram (-0.11) shows continuing bearish momentum without divergence. Bollinger Bands: price ($7.99) sits just below middle ($8.22) and above lower ($7.63) — no squeeze signal, bands wide relative to ATR. 30-day range: price is at ~25.6% of the $6.01–$13.33 band ((7.99-6.01)/(13.33-6.01) = 25.6%), near the lower third.

True Sentiment Analysis (Delta 40-60 Options)

Per the embedded True Sentiment Options file (2026-10-26 10:20):

Call Dollar Volume: $0.00 (0.0%) Put Dollar Volume: $0.00 (0.0%) Total: $0.00

• Sentiment: Balanced (call_pct 0, put_pct 0, total_options_analyzed 252 but true_sentiment_options 0).
• No directional conviction in delta 40-60 filter; filter ratio 0.0%.
• Near-term expectations: neutral — no call or put dollar volume to suggest a directional bet.
• Divergence: Technicals are bearish (price below SMAs, MACD negative) but options flow is flat/balanced, not bearishly positioned. This mismatch implies the market is not expressing directional conviction via near-the-money options.

Key Price Levels (observational only)